Diamond Biofund is a venture capital firm that specializes in investing in early-stage life science companies. The firm focuses on providing capital and strategic support to innovative startups in the biotechnology, pharmaceuticals, and healthcare sectors.

Diamond Biofund

Diamond BioFund is the largest fund dedicated to biotechnology innovation, managing assets worth over 260 million USD. We are also the first evergreen fund in Taiwan, assisting our venture partners to grow continuously. With renowned shareholders including a Fortune 500 enterprise and major financial holding companies in Taiwan, Diamond BioFund is led by an experienced management team with professionals from various backgrounds such as biotech, financial services, and academia, supporting our venture partners with practical knowledge in development and management. Driven by innovation excellence and operation efficiency, Diamond BioFund is committed to becoming the leading biotech venture fund in Taiwan and the global community.

Diamond BioFund currently focuses on healthcare and biotech related industry, including new drugs development, medical devices, health supplements, diagnostics, healthcare retailing channels, and innovative healthcare services. Our investment targets early stage innovative technology with global cutting edge impact. Leveraging the boom in China’s healthcare market, we also target valuable assets in the Greater China region.

Metric
Company Name	Diamond Biofund
Symbol
MSH ID	COM:DIAMONDBIOFUND
Market	PRIVATE
Sector	Financial Services & Finance
Industry	Venture Capital & Private Equity
Country	TW
Stage
Employee Count	7
Website	diamondbiofund.com
LinkedIn	diamond-biofund-inc.
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score	10.36
28-Day Growth Score	16.39
90-Day Growth Score	14.09
365-Day Growth Score	13.03

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:DIAMONDBIOFUND

Diamond Biofund

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue